Global Spinal Muscular Atrophy (SMA) Therapeutic Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Spinal muscular atrophy treatment market growth is driven by a significant increase in the number of product launches despite the relative rarity of the disorder and high costs associated with the approved drugs. The treatment of spinal muscular atrophy through the gene therapy drug called Zolgensma
LPI (LP Information)' newest research report, the “Spinal Muscular Atrophy (SMA) Therapeutic Industry Forecast” looks at past sales and reviews total world Spinal Muscular Atrophy (SMA) Therapeutic sales in 2022, providing a comprehensive analysis by region and market sector of projected Spinal Muscular Atrophy (SMA) Therapeutic sales for 2023 through 2029. With Spinal Muscular Atrophy (SMA) Therapeutic sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Spinal Muscular Atrophy (SMA) Therapeutic industry.
This Insight Report provides a comprehensive analysis of the global Spinal Muscular Atrophy (SMA) Therapeutic landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Spinal Muscular Atrophy (SMA) Therapeutic portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Spinal Muscular Atrophy (SMA) Therapeutic market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Spinal Muscular Atrophy (SMA) Therapeutic and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Spinal Muscular Atrophy (SMA) Therapeutic.
The global Spinal Muscular Atrophy (SMA) Therapeutic market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Spinal Muscular Atrophy (SMA) Therapeutic is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Spinal Muscular Atrophy (SMA) Therapeutic is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Spinal Muscular Atrophy (SMA) Therapeutic is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Spinal Muscular Atrophy (SMA) Therapeutic players cover Biogen, Novartis, Roche, Astellas Pharma and Genzyme Corporation, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Spinal Muscular Atrophy (SMA) Therapeutic market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Spinal muscular atrophy treatment market growth is driven by a significant increase in the number of product launches despite the relative rarity of the disorder and high costs associated with the approved drugs. The treatment of spinal muscular atrophy through the gene therapy drug called Zolgensma
LPI (LP Information)' newest research report, the “Spinal Muscular Atrophy (SMA) Therapeutic Industry Forecast” looks at past sales and reviews total world Spinal Muscular Atrophy (SMA) Therapeutic sales in 2022, providing a comprehensive analysis by region and market sector of projected Spinal Muscular Atrophy (SMA) Therapeutic sales for 2023 through 2029. With Spinal Muscular Atrophy (SMA) Therapeutic sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Spinal Muscular Atrophy (SMA) Therapeutic industry.
This Insight Report provides a comprehensive analysis of the global Spinal Muscular Atrophy (SMA) Therapeutic landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Spinal Muscular Atrophy (SMA) Therapeutic portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Spinal Muscular Atrophy (SMA) Therapeutic market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Spinal Muscular Atrophy (SMA) Therapeutic and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Spinal Muscular Atrophy (SMA) Therapeutic.
The global Spinal Muscular Atrophy (SMA) Therapeutic market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Spinal Muscular Atrophy (SMA) Therapeutic is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Spinal Muscular Atrophy (SMA) Therapeutic is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Spinal Muscular Atrophy (SMA) Therapeutic is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Spinal Muscular Atrophy (SMA) Therapeutic players cover Biogen, Novartis, Roche, Astellas Pharma and Genzyme Corporation, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Spinal Muscular Atrophy (SMA) Therapeutic market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Nusinersen
- Onasemnogen Abeparvovec
- Type 1 SMA
- Type 2 SMA
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Biogen
- Novartis
- Roche
- Astellas Pharma
- Genzyme Corporation
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2018-2029
2.1.2 Spinal Muscular Atrophy (SMA) Therapeutic Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Spinal Muscular Atrophy (SMA) Therapeutic Segment by Type
2.2.1 Nusinersen
2.2.2 Onasemnogen Abeparvovec
2.3 Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type
2.3.1 Spinal Muscular Atrophy (SMA) Therapeutic Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Type (2018-2023)
2.4 Spinal Muscular Atrophy (SMA) Therapeutic Segment by Application
2.4.1 Type 1 SMA
2.4.2 Type 2 SMA
2.4.3 Other
2.5 Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application
2.5.1 Spinal Muscular Atrophy (SMA) Therapeutic Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Application (2018-2023)
3 SPINAL MUSCULAR ATROPHY (SMA) THERAPEUTIC MARKET SIZE BY PLAYER
3.1 Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Players
3.1.1 Global Spinal Muscular Atrophy (SMA) Therapeutic Revenue by Players (2018-2023)
3.1.2 Global Spinal Muscular Atrophy (SMA) Therapeutic Revenue Market Share by Players (2018-2023)
3.2 Global Spinal Muscular Atrophy (SMA) Therapeutic Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 SPINAL MUSCULAR ATROPHY (SMA) THERAPEUTIC BY REGIONS
4.1 Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Regions (2018-2023)
4.2 Americas Spinal Muscular Atrophy (SMA) Therapeutic Market Size Growth (2018-2023)
4.3 APAC Spinal Muscular Atrophy (SMA) Therapeutic Market Size Growth (2018-2023)
4.4 Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size Growth (2018-2023)
4.5 Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Country (2018-2023)
5.2 Americas Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type (2018-2023)
5.3 Americas Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Region (2018-2023)
6.2 APAC Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type (2018-2023)
6.3 APAC Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Spinal Muscular Atrophy (SMA) Therapeutic by Country (2018-2023)
7.2 Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type (2018-2023)
7.3 Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic by Region (2018-2023)
8.2 Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type (2018-2023)
8.3 Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL SPINAL MUSCULAR ATROPHY (SMA) THERAPEUTIC MARKET FORECAST
10.1 Global Spinal Muscular Atrophy (SMA) Therapeutic Forecast by Regions (2024-2029)
10.1.1 Global Spinal Muscular Atrophy (SMA) Therapeutic Forecast by Regions (2024-2029)
10.1.2 Americas Spinal Muscular Atrophy (SMA) Therapeutic Forecast
10.1.3 APAC Spinal Muscular Atrophy (SMA) Therapeutic Forecast
10.1.4 Europe Spinal Muscular Atrophy (SMA) Therapeutic Forecast
10.1.5 Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Forecast
10.2 Americas Spinal Muscular Atrophy (SMA) Therapeutic Forecast by Country (2024-2029)
10.2.1 United States Spinal Muscular Atrophy (SMA) Therapeutic Market Forecast
10.2.2 Canada Spinal Muscular Atrophy (SMA) Therapeutic Market Forecast
10.2.3 Mexico Spinal Muscular Atrophy (SMA) Therapeutic Market Forecast
10.2.4 Brazil Spinal Muscular Atrophy (SMA) Therapeutic Market Forecast
10.3 APAC Spinal Muscular Atrophy (SMA) Therapeutic Forecast by Region (2024-2029)
10.3.1 China Spinal Muscular Atrophy (SMA) Therapeutic Market Forecast
10.3.2 Japan Spinal Muscular Atrophy (SMA) Therapeutic Market Forecast
10.3.3 Korea Spinal Muscular Atrophy (SMA) Therapeutic Market Forecast
10.3.4 Southeast Asia Spinal Muscular Atrophy (SMA) Therapeutic Market Forecast
10.3.5 India Spinal Muscular Atrophy (SMA) Therapeutic Market Forecast
10.3.6 Australia Spinal Muscular Atrophy (SMA) Therapeutic Market Forecast
10.4 Europe Spinal Muscular Atrophy (SMA) Therapeutic Forecast by Country (2024-2029)
10.4.1 Germany Spinal Muscular Atrophy (SMA) Therapeutic Market Forecast
10.4.2 France Spinal Muscular Atrophy (SMA) Therapeutic Market Forecast
10.4.3 UK Spinal Muscular Atrophy (SMA) Therapeutic Market Forecast
10.4.4 Italy Spinal Muscular Atrophy (SMA) Therapeutic Market Forecast
10.4.5 Russia Spinal Muscular Atrophy (SMA) Therapeutic Market Forecast
10.5 Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Forecast by Region (2024-2029)
10.5.1 Egypt Spinal Muscular Atrophy (SMA) Therapeutic Market Forecast
10.5.2 South Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Forecast
10.5.3 Israel Spinal Muscular Atrophy (SMA) Therapeutic Market Forecast
10.5.4 Turkey Spinal Muscular Atrophy (SMA) Therapeutic Market Forecast
10.5.5 GCC Countries Spinal Muscular Atrophy (SMA) Therapeutic Market Forecast
10.6 Global Spinal Muscular Atrophy (SMA) Therapeutic Forecast by Type (2024-2029)
10.7 Global Spinal Muscular Atrophy (SMA) Therapeutic Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Biogen
11.1.1 Biogen Company Information
11.1.2 Biogen Spinal Muscular Atrophy (SMA) Therapeutic Product Offered
11.1.3 Biogen Spinal Muscular Atrophy (SMA) Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Biogen Main Business Overview
11.1.5 Biogen Latest Developments
11.2 Novartis
11.2.1 Novartis Company Information
11.2.2 Novartis Spinal Muscular Atrophy (SMA) Therapeutic Product Offered
11.2.3 Novartis Spinal Muscular Atrophy (SMA) Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Novartis Main Business Overview
11.2.5 Novartis Latest Developments
11.3 Roche
11.3.1 Roche Company Information
11.3.2 Roche Spinal Muscular Atrophy (SMA) Therapeutic Product Offered
11.3.3 Roche Spinal Muscular Atrophy (SMA) Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Roche Main Business Overview
11.3.5 Roche Latest Developments
11.4 Astellas Pharma
11.4.1 Astellas Pharma Company Information
11.4.2 Astellas Pharma Spinal Muscular Atrophy (SMA) Therapeutic Product Offered
11.4.3 Astellas Pharma Spinal Muscular Atrophy (SMA) Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Astellas Pharma Main Business Overview
11.4.5 Astellas Pharma Latest Developments
11.5 Genzyme Corporation
11.5.1 Genzyme Corporation Company Information
11.5.2 Genzyme Corporation Spinal Muscular Atrophy (SMA) Therapeutic Product Offered
11.5.3 Genzyme Corporation Spinal Muscular Atrophy (SMA) Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Genzyme Corporation Main Business Overview
11.5.5 Genzyme Corporation Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2018-2029
2.1.2 Spinal Muscular Atrophy (SMA) Therapeutic Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Spinal Muscular Atrophy (SMA) Therapeutic Segment by Type
2.2.1 Nusinersen
2.2.2 Onasemnogen Abeparvovec
2.3 Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type
2.3.1 Spinal Muscular Atrophy (SMA) Therapeutic Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Type (2018-2023)
2.4 Spinal Muscular Atrophy (SMA) Therapeutic Segment by Application
2.4.1 Type 1 SMA
2.4.2 Type 2 SMA
2.4.3 Other
2.5 Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application
2.5.1 Spinal Muscular Atrophy (SMA) Therapeutic Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Application (2018-2023)
3 SPINAL MUSCULAR ATROPHY (SMA) THERAPEUTIC MARKET SIZE BY PLAYER
3.1 Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Players
3.1.1 Global Spinal Muscular Atrophy (SMA) Therapeutic Revenue by Players (2018-2023)
3.1.2 Global Spinal Muscular Atrophy (SMA) Therapeutic Revenue Market Share by Players (2018-2023)
3.2 Global Spinal Muscular Atrophy (SMA) Therapeutic Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 SPINAL MUSCULAR ATROPHY (SMA) THERAPEUTIC BY REGIONS
4.1 Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Regions (2018-2023)
4.2 Americas Spinal Muscular Atrophy (SMA) Therapeutic Market Size Growth (2018-2023)
4.3 APAC Spinal Muscular Atrophy (SMA) Therapeutic Market Size Growth (2018-2023)
4.4 Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size Growth (2018-2023)
4.5 Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Country (2018-2023)
5.2 Americas Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type (2018-2023)
5.3 Americas Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Region (2018-2023)
6.2 APAC Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type (2018-2023)
6.3 APAC Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Spinal Muscular Atrophy (SMA) Therapeutic by Country (2018-2023)
7.2 Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type (2018-2023)
7.3 Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic by Region (2018-2023)
8.2 Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type (2018-2023)
8.3 Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL SPINAL MUSCULAR ATROPHY (SMA) THERAPEUTIC MARKET FORECAST
10.1 Global Spinal Muscular Atrophy (SMA) Therapeutic Forecast by Regions (2024-2029)
10.1.1 Global Spinal Muscular Atrophy (SMA) Therapeutic Forecast by Regions (2024-2029)
10.1.2 Americas Spinal Muscular Atrophy (SMA) Therapeutic Forecast
10.1.3 APAC Spinal Muscular Atrophy (SMA) Therapeutic Forecast
10.1.4 Europe Spinal Muscular Atrophy (SMA) Therapeutic Forecast
10.1.5 Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Forecast
10.2 Americas Spinal Muscular Atrophy (SMA) Therapeutic Forecast by Country (2024-2029)
10.2.1 United States Spinal Muscular Atrophy (SMA) Therapeutic Market Forecast
10.2.2 Canada Spinal Muscular Atrophy (SMA) Therapeutic Market Forecast
10.2.3 Mexico Spinal Muscular Atrophy (SMA) Therapeutic Market Forecast
10.2.4 Brazil Spinal Muscular Atrophy (SMA) Therapeutic Market Forecast
10.3 APAC Spinal Muscular Atrophy (SMA) Therapeutic Forecast by Region (2024-2029)
10.3.1 China Spinal Muscular Atrophy (SMA) Therapeutic Market Forecast
10.3.2 Japan Spinal Muscular Atrophy (SMA) Therapeutic Market Forecast
10.3.3 Korea Spinal Muscular Atrophy (SMA) Therapeutic Market Forecast
10.3.4 Southeast Asia Spinal Muscular Atrophy (SMA) Therapeutic Market Forecast
10.3.5 India Spinal Muscular Atrophy (SMA) Therapeutic Market Forecast
10.3.6 Australia Spinal Muscular Atrophy (SMA) Therapeutic Market Forecast
10.4 Europe Spinal Muscular Atrophy (SMA) Therapeutic Forecast by Country (2024-2029)
10.4.1 Germany Spinal Muscular Atrophy (SMA) Therapeutic Market Forecast
10.4.2 France Spinal Muscular Atrophy (SMA) Therapeutic Market Forecast
10.4.3 UK Spinal Muscular Atrophy (SMA) Therapeutic Market Forecast
10.4.4 Italy Spinal Muscular Atrophy (SMA) Therapeutic Market Forecast
10.4.5 Russia Spinal Muscular Atrophy (SMA) Therapeutic Market Forecast
10.5 Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Forecast by Region (2024-2029)
10.5.1 Egypt Spinal Muscular Atrophy (SMA) Therapeutic Market Forecast
10.5.2 South Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Forecast
10.5.3 Israel Spinal Muscular Atrophy (SMA) Therapeutic Market Forecast
10.5.4 Turkey Spinal Muscular Atrophy (SMA) Therapeutic Market Forecast
10.5.5 GCC Countries Spinal Muscular Atrophy (SMA) Therapeutic Market Forecast
10.6 Global Spinal Muscular Atrophy (SMA) Therapeutic Forecast by Type (2024-2029)
10.7 Global Spinal Muscular Atrophy (SMA) Therapeutic Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Biogen
11.1.1 Biogen Company Information
11.1.2 Biogen Spinal Muscular Atrophy (SMA) Therapeutic Product Offered
11.1.3 Biogen Spinal Muscular Atrophy (SMA) Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Biogen Main Business Overview
11.1.5 Biogen Latest Developments
11.2 Novartis
11.2.1 Novartis Company Information
11.2.2 Novartis Spinal Muscular Atrophy (SMA) Therapeutic Product Offered
11.2.3 Novartis Spinal Muscular Atrophy (SMA) Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Novartis Main Business Overview
11.2.5 Novartis Latest Developments
11.3 Roche
11.3.1 Roche Company Information
11.3.2 Roche Spinal Muscular Atrophy (SMA) Therapeutic Product Offered
11.3.3 Roche Spinal Muscular Atrophy (SMA) Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Roche Main Business Overview
11.3.5 Roche Latest Developments
11.4 Astellas Pharma
11.4.1 Astellas Pharma Company Information
11.4.2 Astellas Pharma Spinal Muscular Atrophy (SMA) Therapeutic Product Offered
11.4.3 Astellas Pharma Spinal Muscular Atrophy (SMA) Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Astellas Pharma Main Business Overview
11.4.5 Astellas Pharma Latest Developments
11.5 Genzyme Corporation
11.5.1 Genzyme Corporation Company Information
11.5.2 Genzyme Corporation Spinal Muscular Atrophy (SMA) Therapeutic Product Offered
11.5.3 Genzyme Corporation Spinal Muscular Atrophy (SMA) Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Genzyme Corporation Main Business Overview
11.5.5 Genzyme Corporation Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Spinal Muscular Atrophy (SMA) Therapeutic Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Nusinersen
Table 3. Major Players of Onasemnogen Abeparvovec
Table 4. Spinal Muscular Atrophy (SMA) Therapeutic Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Type (2018-2023)
Table 7. Spinal Muscular Atrophy (SMA) Therapeutic Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Application (2018-2023)
Table 10. Global Spinal Muscular Atrophy (SMA) Therapeutic Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Spinal Muscular Atrophy (SMA) Therapeutic Revenue Market Share by Player (2018-2023)
Table 12. Spinal Muscular Atrophy (SMA) Therapeutic Key Players Head office and Products Offered
Table 13. Spinal Muscular Atrophy (SMA) Therapeutic Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Regions (2018-2023)
Table 18. Global Spinal Muscular Atrophy (SMA) Therapeutic Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Spinal Muscular Atrophy (SMA) Therapeutic Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Country (2018-2023)
Table 22. Americas Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Type (2018-2023)
Table 24. Americas Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Application (2018-2023)
Table 26. APAC Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Region (2018-2023)
Table 28. APAC Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Type (2018-2023)
Table 30. APAC Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Application (2018-2023)
Table 32. Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Country (2018-2023)
Table 34. Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Type (2018-2023)
Table 36. Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Spinal Muscular Atrophy (SMA) Therapeutic
Table 45. Key Market Challenges & Risks of Spinal Muscular Atrophy (SMA) Therapeutic
Table 46. Key Industry Trends of Spinal Muscular Atrophy (SMA) Therapeutic
Table 47. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. Biogen Details, Company Type, Spinal Muscular Atrophy (SMA) Therapeutic Area Served and Its Competitors
Table 52. Biogen Spinal Muscular Atrophy (SMA) Therapeutic Product Offered
Table 53. Biogen Spinal Muscular Atrophy (SMA) Therapeutic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. Biogen Main Business
Table 55. Biogen Latest Developments
Table 56. Novartis Details, Company Type, Spinal Muscular Atrophy (SMA) Therapeutic Area Served and Its Competitors
Table 57. Novartis Spinal Muscular Atrophy (SMA) Therapeutic Product Offered
Table 58. Novartis Main Business
Table 59. Novartis Spinal Muscular Atrophy (SMA) Therapeutic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Novartis Latest Developments
Table 61. Roche Details, Company Type, Spinal Muscular Atrophy (SMA) Therapeutic Area Served and Its Competitors
Table 62. Roche Spinal Muscular Atrophy (SMA) Therapeutic Product Offered
Table 63. Roche Main Business
Table 64. Roche Spinal Muscular Atrophy (SMA) Therapeutic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Roche Latest Developments
Table 66. Astellas Pharma Details, Company Type, Spinal Muscular Atrophy (SMA) Therapeutic Area Served and Its Competitors
Table 67. Astellas Pharma Spinal Muscular Atrophy (SMA) Therapeutic Product Offered
Table 68. Astellas Pharma Main Business
Table 69. Astellas Pharma Spinal Muscular Atrophy (SMA) Therapeutic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Astellas Pharma Latest Developments
Table 71. Genzyme Corporation Details, Company Type, Spinal Muscular Atrophy (SMA) Therapeutic Area Served and Its Competitors
Table 72. Genzyme Corporation Spinal Muscular Atrophy (SMA) Therapeutic Product Offered
Table 73. Genzyme Corporation Main Business
Table 74. Genzyme Corporation Spinal Muscular Atrophy (SMA) Therapeutic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Genzyme Corporation Latest Developments
Table 1. Spinal Muscular Atrophy (SMA) Therapeutic Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Nusinersen
Table 3. Major Players of Onasemnogen Abeparvovec
Table 4. Spinal Muscular Atrophy (SMA) Therapeutic Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Type (2018-2023)
Table 7. Spinal Muscular Atrophy (SMA) Therapeutic Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Application (2018-2023)
Table 10. Global Spinal Muscular Atrophy (SMA) Therapeutic Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Spinal Muscular Atrophy (SMA) Therapeutic Revenue Market Share by Player (2018-2023)
Table 12. Spinal Muscular Atrophy (SMA) Therapeutic Key Players Head office and Products Offered
Table 13. Spinal Muscular Atrophy (SMA) Therapeutic Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Regions (2018-2023)
Table 18. Global Spinal Muscular Atrophy (SMA) Therapeutic Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Spinal Muscular Atrophy (SMA) Therapeutic Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Country (2018-2023)
Table 22. Americas Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Type (2018-2023)
Table 24. Americas Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Application (2018-2023)
Table 26. APAC Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Region (2018-2023)
Table 28. APAC Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Type (2018-2023)
Table 30. APAC Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Application (2018-2023)
Table 32. Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Country (2018-2023)
Table 34. Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Type (2018-2023)
Table 36. Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Spinal Muscular Atrophy (SMA) Therapeutic
Table 45. Key Market Challenges & Risks of Spinal Muscular Atrophy (SMA) Therapeutic
Table 46. Key Industry Trends of Spinal Muscular Atrophy (SMA) Therapeutic
Table 47. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. Biogen Details, Company Type, Spinal Muscular Atrophy (SMA) Therapeutic Area Served and Its Competitors
Table 52. Biogen Spinal Muscular Atrophy (SMA) Therapeutic Product Offered
Table 53. Biogen Spinal Muscular Atrophy (SMA) Therapeutic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. Biogen Main Business
Table 55. Biogen Latest Developments
Table 56. Novartis Details, Company Type, Spinal Muscular Atrophy (SMA) Therapeutic Area Served and Its Competitors
Table 57. Novartis Spinal Muscular Atrophy (SMA) Therapeutic Product Offered
Table 58. Novartis Main Business
Table 59. Novartis Spinal Muscular Atrophy (SMA) Therapeutic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Novartis Latest Developments
Table 61. Roche Details, Company Type, Spinal Muscular Atrophy (SMA) Therapeutic Area Served and Its Competitors
Table 62. Roche Spinal Muscular Atrophy (SMA) Therapeutic Product Offered
Table 63. Roche Main Business
Table 64. Roche Spinal Muscular Atrophy (SMA) Therapeutic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Roche Latest Developments
Table 66. Astellas Pharma Details, Company Type, Spinal Muscular Atrophy (SMA) Therapeutic Area Served and Its Competitors
Table 67. Astellas Pharma Spinal Muscular Atrophy (SMA) Therapeutic Product Offered
Table 68. Astellas Pharma Main Business
Table 69. Astellas Pharma Spinal Muscular Atrophy (SMA) Therapeutic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Astellas Pharma Latest Developments
Table 71. Genzyme Corporation Details, Company Type, Spinal Muscular Atrophy (SMA) Therapeutic Area Served and Its Competitors
Table 72. Genzyme Corporation Spinal Muscular Atrophy (SMA) Therapeutic Product Offered
Table 73. Genzyme Corporation Main Business
Table 74. Genzyme Corporation Spinal Muscular Atrophy (SMA) Therapeutic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Genzyme Corporation Latest Developments
LIST OF FIGURES
Figure 1. Spinal Muscular Atrophy (SMA) Therapeutic Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Spinal Muscular Atrophy (SMA) Therapeutic Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Spinal Muscular Atrophy (SMA) Therapeutic Sales Market Share by Country/Region (2022)
Figure 8. Spinal Muscular Atrophy (SMA) Therapeutic Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Type in 2022
Figure 10. Spinal Muscular Atrophy (SMA) Therapeutic in Type 1 SMA
Figure 11. Global Spinal Muscular Atrophy (SMA) Therapeutic Market: Type 1 SMA (2018-2023) & ($ Millions)
Figure 12. Spinal Muscular Atrophy (SMA) Therapeutic in Type 2 SMA
Figure 13. Global Spinal Muscular Atrophy (SMA) Therapeutic Market: Type 2 SMA (2018-2023) & ($ Millions)
Figure 14. Spinal Muscular Atrophy (SMA) Therapeutic in Other
Figure 15. Global Spinal Muscular Atrophy (SMA) Therapeutic Market: Other (2018-2023) & ($ Millions)
Figure 16. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Application in 2022
Figure 17. Global Spinal Muscular Atrophy (SMA) Therapeutic Revenue Market Share by Player in 2022
Figure 18. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2018-2023 ($ Millions)
Figure 20. APAC Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2018-2023 ($ Millions)
Figure 21. Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2018-2023 ($ Millions)
Figure 23. Americas Spinal Muscular Atrophy (SMA) Therapeutic Value Market Share by Country in 2022
Figure 24. United States Spinal Muscular Atrophy (SMA) Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Spinal Muscular Atrophy (SMA) Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Spinal Muscular Atrophy (SMA) Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Spinal Muscular Atrophy (SMA) Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Region in 2022
Figure 29. APAC Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Type in 2022
Figure 30. APAC Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Application in 2022
Figure 31. China Spinal Muscular Atrophy (SMA) Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Spinal Muscular Atrophy (SMA) Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Spinal Muscular Atrophy (SMA) Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Spinal Muscular Atrophy (SMA) Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Spinal Muscular Atrophy (SMA) Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Spinal Muscular Atrophy (SMA) Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Country in 2022
Figure 38. Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Type (2018-2023)
Figure 39. Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Application (2018-2023)
Figure 40. Germany Spinal Muscular Atrophy (SMA) Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Spinal Muscular Atrophy (SMA) Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Spinal Muscular Atrophy (SMA) Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Spinal Muscular Atrophy (SMA) Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Spinal Muscular Atrophy (SMA) Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Spinal Muscular Atrophy (SMA) Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Spinal Muscular Atrophy (SMA) Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Spinal Muscular Atrophy (SMA) Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Spinal Muscular Atrophy (SMA) Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2024-2029 ($ Millions)
Figure 54. APAC Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2024-2029 ($ Millions)
Figure 55. Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2024-2029 ($ Millions)
Figure 57. United States Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2024-2029 ($ Millions)
Figure 58. Canada Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2024-2029 ($ Millions)
Figure 61. China Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2024-2029 ($ Millions)
Figure 62. Japan Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2024-2029 ($ Millions)
Figure 63. Korea Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2024-2029 ($ Millions)
Figure 65. India Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2024-2029 ($ Millions)
Figure 66. Australia Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2024-2029 ($ Millions)
Figure 67. Germany Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2024-2029 ($ Millions)
Figure 68. France Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2024-2029 ($ Millions)
Figure 69. UK Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2024-2029 ($ Millions)
Figure 70. Italy Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2024-2029 ($ Millions)
Figure 71. Russia Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2024-2029 ($ Millions)
Figure 72. Spain Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2024-2029 ($ Millions)
Figure 75. Israel Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2024-2029 ($ Millions)
Figure 78. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Spinal Muscular Atrophy (SMA) Therapeutic Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Spinal Muscular Atrophy (SMA) Therapeutic Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Spinal Muscular Atrophy (SMA) Therapeutic Sales Market Share by Country/Region (2022)
Figure 8. Spinal Muscular Atrophy (SMA) Therapeutic Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Type in 2022
Figure 10. Spinal Muscular Atrophy (SMA) Therapeutic in Type 1 SMA
Figure 11. Global Spinal Muscular Atrophy (SMA) Therapeutic Market: Type 1 SMA (2018-2023) & ($ Millions)
Figure 12. Spinal Muscular Atrophy (SMA) Therapeutic in Type 2 SMA
Figure 13. Global Spinal Muscular Atrophy (SMA) Therapeutic Market: Type 2 SMA (2018-2023) & ($ Millions)
Figure 14. Spinal Muscular Atrophy (SMA) Therapeutic in Other
Figure 15. Global Spinal Muscular Atrophy (SMA) Therapeutic Market: Other (2018-2023) & ($ Millions)
Figure 16. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Application in 2022
Figure 17. Global Spinal Muscular Atrophy (SMA) Therapeutic Revenue Market Share by Player in 2022
Figure 18. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2018-2023 ($ Millions)
Figure 20. APAC Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2018-2023 ($ Millions)
Figure 21. Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2018-2023 ($ Millions)
Figure 23. Americas Spinal Muscular Atrophy (SMA) Therapeutic Value Market Share by Country in 2022
Figure 24. United States Spinal Muscular Atrophy (SMA) Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Spinal Muscular Atrophy (SMA) Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Spinal Muscular Atrophy (SMA) Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Spinal Muscular Atrophy (SMA) Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Region in 2022
Figure 29. APAC Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Type in 2022
Figure 30. APAC Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Application in 2022
Figure 31. China Spinal Muscular Atrophy (SMA) Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Spinal Muscular Atrophy (SMA) Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Spinal Muscular Atrophy (SMA) Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Spinal Muscular Atrophy (SMA) Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Spinal Muscular Atrophy (SMA) Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Spinal Muscular Atrophy (SMA) Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Country in 2022
Figure 38. Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Type (2018-2023)
Figure 39. Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Application (2018-2023)
Figure 40. Germany Spinal Muscular Atrophy (SMA) Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Spinal Muscular Atrophy (SMA) Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Spinal Muscular Atrophy (SMA) Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Spinal Muscular Atrophy (SMA) Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Spinal Muscular Atrophy (SMA) Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Spinal Muscular Atrophy (SMA) Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Spinal Muscular Atrophy (SMA) Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Spinal Muscular Atrophy (SMA) Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Spinal Muscular Atrophy (SMA) Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2024-2029 ($ Millions)
Figure 54. APAC Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2024-2029 ($ Millions)
Figure 55. Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2024-2029 ($ Millions)
Figure 57. United States Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2024-2029 ($ Millions)
Figure 58. Canada Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2024-2029 ($ Millions)
Figure 61. China Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2024-2029 ($ Millions)
Figure 62. Japan Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2024-2029 ($ Millions)
Figure 63. Korea Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2024-2029 ($ Millions)
Figure 65. India Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2024-2029 ($ Millions)
Figure 66. Australia Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2024-2029 ($ Millions)
Figure 67. Germany Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2024-2029 ($ Millions)
Figure 68. France Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2024-2029 ($ Millions)
Figure 69. UK Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2024-2029 ($ Millions)
Figure 70. Italy Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2024-2029 ($ Millions)
Figure 71. Russia Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2024-2029 ($ Millions)
Figure 72. Spain Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2024-2029 ($ Millions)
Figure 75. Israel Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2024-2029 ($ Millions)
Figure 78. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share Forecast by Application (2024-2029)
